keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 2
keyboard_arrow_leftSearch & Filter
search
Streams
Day 2
search
Streams
8:00am - 8:30am
Registration and Coffee
Plenary Session
Showing 1 of 1 Streams
Plenary Session
8:30am - 8:35am
Chairperson’s Remarks: Plenary Day 2
- Shiro Akinaga, PhD - President and CEO, NANO MRNA, Co., Ltd.
8:35am - 9:05am
From Circles to Conjugates: Rethinking the Architecture of guide RNA
- Brian Cafferty, PhD - Director, Beam Therapeutics
9:05am - 9:35am
Improving Oligonucleotide Pharmacology Across Tissues and Modalities through Base, Sugar, and Backbone Modifications
- Michael Byrne, Ph.D. - Vice President, In Vivo and CNS Biology, Wave Life Sciences
9:35am - 10:15am
Networking Refreshment Break with Poster and Exhibit Viewing
Concurrent Conference Tracks
Showing 2 of 2 Streams
Track 1
Track 2
10:15am - 10:20am
Chairperson’s Remarks: Track 1
- Shiro Akinaga, PhD - President and CEO, NANO MRNA, Co., Ltd.
10:20am - 10:50am
Amide-Modified Oligonucleotides for Chemical Control of Functional RNAs
- Eriks Rozners, Ph.D. - Professor and Chair of Chemistry Department, Binghamton University
10:50am - 11:20am
Chemical Approaches to Enhance siRNA Selectivity
- Mehran Nikan, Ph.D. - Research Fellow, Ionis Pharmaceuticals Inc
11:20am - 11:50am
Synthetic Strategy for Ligand Conjugated Oligonucleotides via Diamine Modified Stable Phosphoroamidite
- Mitsuaki Sekiguchi, Ph.D. - Principal Scientist, Biopharmaceutical Research Di, Shionogi & Co., Ltd.
10:15am - 10:20am
Chairperson’s Remarks: Track 2
- Kunwoo Lee, PhD - Chief Executive Officer, GenEdit
10:20am - 10:50am
Synthesizing Long Guide RNAs for In Vivo Prime Editing
- Rowshon Alam, Ph.D. - Senior Director, Head of Process Chemistry, Prime Medicine
10:50am - 11:20am
Addressing the Regulatory Expectations for Guide RNA Quality While Providing Manufacturing Capacity
- Blake Unterreiner - Associate Vice President, Business Development & Customer Relations, Agilent Technologies
11:20am - 11:50am
Delivery of Genetic Medicine with Hydrophilic Nanoparticles
- Kunwoo Lee, PhD - Chief Executive Officer, GenEdit
11:50am - 12:55pm
Networking Luncheon with Poster and Exhibit Viewing
Showing 2 of 2 Streams
Track 1
Track 2
12:55pm - 1:00pm
Chairperson’s Remarks: Track 1
- Hideaki Sato - President and CEO, Luxna Biotech
1:00pm - 1:30pm
Comprehensive Analysis of Brain Distribution for Antisense Oligonucleotides Using Whole Tissue Imaging Technique
- Syunsuke Yamamoto - Associate Director, Takeda Pharmaceutical Company
1:30pm - 2:00pm
In vivo Genome Editing: Translating Science from Bench to Bedside
- Zi Jun Emma Wang, PhD - Chief Technology Officer, YolTech Therapeutics
2:00pm - 2:30pm
Nucleic Acid Therapeutics: Process Optimization and Purification
- Lulu Zhang, PhD - Field Application Scientist, Thermo Fisher Scientific
2:30pm - 3:00pm
Peptide-Oligonucleotides Conjugates from a CDMO Perspective
- Loic Cornelissen, PhD - Associate Director, Business Development, PolyPeptide Group
12:55pm - 1:00pm
Chairperson’s Remarks: Track 2
- Naoki Yamamoto, PhD - Head of Business Development, Asia Pacific, Bachem Japan K.K.
1:00pm - 1:30pm
Acceleration of Process Development for GMP Production of Peptides
- Dewey Sutton, PhD - Research and Development Supervisor, AmbioPharm
1:30pm - 2:00pm
Recent Technological Innovation in Peptide Manufacturing
- Yoshitaka Nemoto - Vice President R&D, PeptiStar
2:00pm - 2:30pm
De Novo Discovery of Natural Product-like Thiopeptides with Designed Biological Activities
- Alexander Vinogradov, PhD - Project Assistant Professor, The University of Tokyo
2:30pm - 3:00pm
Discovery of Zilucoplan: A Potent Macrocyclic Peptide Complement Component 5 (C5) Inhibitor in Acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis
- Ping Ye - Senior Scientist II, UCB
3:00pm - 3:30pm
Networking Refreshment Break with Poster and Exhibit Viewing
Showing 2 of 2 Streams
Track 1
Track 2
3:30pm - 4:00pm
Going Large-scale with Manufacturing of Oligonucleotides
- Daniel Samson, PhD - Vice President, Head Oligonucleotides, Bachem AG
4:00pm - 4:30pm
Synthesis PAT: IR Spectroscopy for Real-Time Phosphoramidite Identification
- Spenser Pruett - Scientist II, Process Development, Nitto Avecia
4:30pm - 5:00pm
Addressing Complex Oligonucleotide Therapeutics and Approach Towards Endotoxin Removal
- Juergen Mueller, PhD - Vice President of Commercial Operations, LGC Axolabs
- Xiaocen (Chris) Li, PhD - Supervisor, LGC Axolabs
5:00pm - 5:30pm
New Ligation Approach: Technology for High Quality Manufacturing of Over 150 mer RNA
- Masato Sanosaka, PhD - Group Leader of Research & Process Development, Ajinomoto Biopharma Services
3:30pm - 4:00pm
Macrocyclic Peptide Drug Development by Combining the Strengths of all Small Fragments, mRNA Display and AI Technologies
- Hwanho Choi, M.D., Ph.D. - CEO and Founder, Quantum Intelligence Corporation
4:00pm - 4:30pm
From Discovery to the Clinic: Development of a Novel Bioactive Peptide that Improves Mood and Cognition by Engaging the Gut-Brain Axis
- Kousaku Ohinata, Ph.D. - Founder and Scientific Advisor, Viage Therapeutics
4:30pm - 5:00pm
A Purely Thermodynamic Anti-prionic Mode of Action for Protein-misfolding Diseases is Realized by All-D-peptides
- Dieter Willbold, Ph.D. - Director and Full Professor, Forschungszentrum Jülich
5:00pm - 5:30pm
In Cellulo Library-derived Peptide-based Inhibitors of Alpha-synuclein Aggregation and Toxicity
- Jody Mason, PhD - Professor of Biochemistry, University of Bath
5:30pm - 6:30pm
Networking Cocktail Reception with Poster and Exhibit Viewing
Please join your fellow attendees in the exhibit hall for an evening of networking while enjoying beverages and appetizers.
6:30pm - 6:35pm
Close of Day Two
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Choose Day